Results 1 to 10 of about 25,789 (163)

Combined oral contraceptive use as a cause of acute myocardial infarction in a young woman without traditional risk factors: a case report [PDF]

Journal of Medical Case Reports
Background Combined oral contraceptives are widely used and generally considered safe. However, they have been associated with arterial thrombosis, including myocardial infarction, particularly in women with cardiovascular risk factors. This case adds to
Seyed Kianoosh Hosseini, Hosseinali Mohammadi, Seyyed Alireza Mohammadi   +2 more
doaj   +2 more sources

Investigating cardiovascular risk in premenopausal women on oral contraceptives: Systematic review with meta-analysis

Frontiers in Cardiovascular Medicine, 2023
BackgroundThe use of oral contraceptives (OCs) is associated with an increased risk of cardiovascular events such as arterial and venous thrombosis (VTE).
Oyesanmi A. Fabunmi, Oyesanmi A. Fabunmi, Phiwayinkosi V. Dludla, Bongani B. Nkambule   +3 more
doaj   +1 more source

Oral contraceptives and tissue factor expression. Comments on “Do combined oral contraceptives induce formation of tissue factor?” [PDF]

Research and Practice in Thrombosis and Haemostasis
Bjarne Østerud
doaj   +2 more sources

Estimate of venous thromboembolism and related-deaths attributable to the use of combined oral contraceptives in France. [PDF]

PLoS ONE, 2014
PURPOSE: To estimate the number of venous thromboembolic events and related-premature mortality (including immediate in-hospital lethality) attributable to the use of combined oral contraceptives in women aged 15 to 49 years-old between 2000 and 2011 in ...
Aurore Tricotel, Fanny Raguideau, Cédric Collin, Mahmoud Zureik   +3 more
doaj   +1 more source

Thrombin generation in a woman with heterozygous factor V Leiden and combined oral contraceptives: A case report

Research and Practice in Thrombosis and Haemostasis, 2020
Combined oral contraceptives and factor V Leiden mutation are multiplicative risk factors for venous thromboembolism. However, it remains unknown whether this multiplicative effect is reflected in thrombin generation assays.
Maxime G. Zermatten, Debora Bertaggia Calderara, Alessandro Aliotta, Lorenzo Alberio   +3 more
doaj   +1 more source

Reproductive behavior of medical students: realities of contraceptive choice [PDF]

Гинекология, 2018
Representations of the society about the use of hormonal drugs for protection from unwanted pregnancy have the features of a deeply rooted behavioral and social stigmatization.
T A Oboskalova, O V Prohorova
doaj   +1 more source

Thromboembolic safety of norethisterone vs levonorgestrel in combined oral contraceptive users: a pooled analysis of 4 large prospective cohort studiesAJOG Global Reports at a Glance

AJOG Global Reports, 2022
BACKGROUND: Norethisterone (acetate) and levonorgestrel are marketed globally as components of combined oral contraceptives. Although guidelines recommend both as first-line combined oral contraceptives, no direct, comparative safety studies are ...
Clare Barnett, MBBS (Hons), MPH, Anja Bauerfeind, PhD, Sophia Von Stockum, PhD, Klaas Heinemann, MD, PhD, MSc, MBA   +3 more
doaj   +1 more source

Selected effects of combined oral contraceptives use

Journal of Education, Health and Sport, 2022
Introduction and objective:: Combined oral contraceptives (COCs) are one of the most popular methods of contraception worldwide. The universality of this method leads to the constant analysis of its influence on the female body.
Julia Bogucka, Anna Brzyska, Natalia Domańska, Małgorzata Bojarska, Natalia Wilczek, Halina Piecewicz-Szczęsna   +5 more
doaj   +1 more source

Topical issues in combined oral contraceptives usage [PDF]

Гинекология, 2018
The article presents topical issues of combined oral contraceptive (COC) use: among women with obesity, the effectiveness of COC in the management of premenstrual syndrome, the risk of thrombosis among women using of COCs and the economic justification ...
S O Dubrovina
doaj   +1 more source

Combined oral contraception and cancer [PDF]

Journal of Family Planning and Reproductive Health Care, 2000
Since their introduction in the 1960s the safety of combined oral contraceptives (COCs) has been widely debated. The difficulty in determining if COC use increases the risk of developing cancer is due to: • the long latent period between exposure to the potential carcinogen and overt malignant disease • the fact that due to the developments in COCs ...
openaire   +2 more sources